- Home
- LSTA vs RDI Comparison
LSTA vs RDI Comparison
Compare LSTA & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- RDI
- Stock Information
- Founded
- LSTA 1980
- RDI 1937
- Country
- LSTA United States
- RDI United States
- Employees
- LSTA N/A
- RDI N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- RDI Movies/Entertainment
- Sector
- LSTA Health Care
- RDI Consumer Discretionary
- Exchange
- LSTA Nasdaq
- RDI Nasdaq
- Market Cap
- LSTA 22.9M
- RDI 31.6M
- IPO Year
- LSTA N/A
- RDI N/A
- Fundamental
- Price
- LSTA $3.10
- RDI $1.80
- Analyst Decision
- LSTA Strong Buy
- RDI Hold
- Analyst Count
- LSTA 1
- RDI 1
- Target Price
- LSTA $15.00
- RDI $2.40
- AVG Volume (30 Days)
- LSTA 8.1K
- RDI 20.8K
- Earning Date
- LSTA 10-31-2024
- RDI 08-14-2024
- Dividend Yield
- LSTA N/A
- RDI N/A
- EPS Growth
- LSTA N/A
- RDI N/A
- EPS
- LSTA N/A
- RDI N/A
- Revenue
- LSTA N/A
- RDI $203,744,000.00
- Revenue This Year
- LSTA N/A
- RDI N/A
- Revenue Next Year
- LSTA N/A
- RDI $16.86
- P/E Ratio
- LSTA N/A
- RDI N/A
- Revenue Growth
- LSTA N/A
- RDI N/A
- 52 Week Low
- LSTA $1.95
- RDI $1.22
- 52 Week High
- LSTA $3.83
- RDI $2.34
- Technical
- Relative Strength Index (RSI)
- LSTA 52.52
- RDI 62.35
- Support Level
- LSTA $2.74
- RDI $1.54
- Resistance Level
- LSTA $3.07
- RDI $1.82
- Average True Range (ATR)
- LSTA 0.20
- RDI 0.13
- MACD
- LSTA 0.05
- RDI 0.01
- Stochastic Oscillator
- LSTA 61.29
- RDI 92.68
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.